Skip to content

Opioid-free Anesthesia as an Alternative to General Anesthesia in Patients Undergoing Laparoscopic Peripheral Pancreatic Resection

Opioid-free Anesthesia as an Alternative to General Anesthesia in Patients Undergoing Laparoscopic Peripheral Pancreatic Resection

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07378189
Acronym
OFAPP
Enrollment
200
Registered
2026-01-30
Start date
2026-09-02
Completion date
2027-12-31
Last updated
2026-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain Management

Keywords

Pain, OFA, Opioid Free Anesthesia

Brief summary

Opioid-free anesthesia is not associated with greater pain than opioid anesthesia and is associated with reduced postoperative pain.

Detailed description

In our study, the investigators would like to compare the measurement of total oxycodone consumption in the postoperative period in both groups and whether the use of opioid-free anesthesia would reduce opioid consumption by 30%. The secondary objective will be to assess pain in both groups during the first 48 postoperative hours in patients undergoing pancreatic surgery. Patients would be randomly assigned to anesthesia with and without opioids at 1, 2, 6, 12, 24, and 48 hours after surgery. Other secondary objectives include assessing the incidence of postoperative nausea and vomiting (PONV), adverse drug reactions, particularly cardiac arrhythmias, and the impact on persistent postoperative pain. On day 7 after surgery, each patient will receive the QOR-15 questionnaire to assess quality of life and the PQA-10 questionnaire.

Interventions

OTHEROpioid Free Anesthesia (OFA)

Patients who will have pancreatic operation under Opioid Free anesthesia

DRUGBalanced anesthesia with opioids

Patients who will hav pancreatic operation under balanced anesthesia including opioids

Sponsors

Jagiellonian University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patient consent to participate in the study * Qualified for laparoscopic peripheral pancreatic resection * Age 18-80 years * ASA II and III

Exclusion criteria

* Patient refusal to participate in the study * Inability to operate a PCA pump * Lack of understanding of the NRS scale * Hypersensitivity to anesthetics * First- or second-degree heart block.

Design outcomes

Primary

MeasureTime frameDescription
Opioid consumptionup to 48 hours after surgerymeasurement of total oxycodone consumption in the postoperative period

Secondary

MeasureTime frameDescription
Pain assessmentat 1, 2, 6, 12, 24, and 48 hours after surgeryAssessment of pain at 1, 2, 6, 12, 24, and 48 hours after surgery by NRS scale (0-10, 0 - no pain, 10 worst pain imaginable)
PONVup to 48 h after surgeryassessment of the occurrence of postoperative nausea and vomiting (PONV)
Quality Of Recoveryon the 7th day after surgeryQOR-15 questionnaire to assess quality of life and PQA-10 questionnaire. The QOR-15 is a 15 items questionnaire which provides a valid and efficient evaluation of the postoperative quality of recovery. The QoR 15 score is a score of 15 items, each scored from 0 to 10. These items assess 5 dimensions of post-operative recovery: pain, physical comfort, functional autonomy, emotions and psychological support. These 15 items represent the quality of post-operative rehabilitation in its physical and mental dimensions

Countries

Poland

Contacts

CONTACTMichal Cicio, MD
michal.cicio@uj.edu.pl124001800

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 5, 2026